Ocular Therapeutix, Inc. (OCUL)

NASDAQ: OCUL · Real-Time Price · USD

11.52

+0.55 (5.01%)

At close: Oct 7, 2025, 4:00 PM EDT

11.54

+0.02 (0.17%)

After-hours: Oct 7, 2025, 7:57 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Bioresorbable Hydrogel-based Formulation Technology	63.46M	Log In	Log In	Log In	Log In	Upgrade
Bioresorbable Hydrogel-based Formulation Technology Growth	9.66%	Log In	Log In	Log In	Log In	Upgrade
Collaboration	262.00K	Log In	Log In	Log In	Log In	Upgrade
Collaboration Growth	-54.28%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	63.72M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	9.03%	Log In	Log In	Log In	Log In	Upgrade